Natera Women's Health

✨📚 Epic User Group Meeting 2024 is just around the corner! 📚 ✨Be sure to swing by our booth and learn how Natera’s EMR integration is bringing together leaders in healthcare and informatics. #Natera https://ow.ly/lxAb50SZOsr #HealthData #Innovation

Our Empower Hereditary Cancer Test has five panel options with up to 81 genes across 12+ common hereditary cancer types, and customizable gene panels with 190+ gene options. Genes can be selected individually or added by selecting a particular organ system of interest. This test is particularly important for those who want to know more about their risk of developing cancer, why it might be common in their family, or want to inform treatment options following a cancer diagnosis. Learn more below. https://ow.ly/XINT50SZme9 #HereditaryCancer #Natera #KnowledgeisEmpower

Join us Wednesday, August 21 for this exciting webinar sponsored by @nateragenetics 📝 In this presentation, we will: ✅ Review RhD and its role in pregnancy. ✅ See a clinical validation study including 655 Rh negative pregnant people and confirmation by serology on all newborns ✅Discuss how fetal RhD NIPT adds to current management of pregnant people who are Rh negative Register now: https://lnkd.in/gwdhpe3w

🤰 In case you missed our webinar, you can now view it on demand! | It's time to screen routinely for 22q11.2 deletion syndrome (DS): new evidence of improved outcomes with prenatal diagnosis. This webinar reviews recent publications with findings that add to what is known about the diagnosis and management of 22q DS in routine practice. Watch here 👇 https://ow.ly/3N5p50SRc81 #Natera #22Q #Prenatal

Want to learn more about the clinical validation study on Natera’s Fetal RhD NIPT? Jeffrey T. Meltzer, MD, MBA, senior medical director at Natera explains the data! Watch the full breakdown below. https://ow.ly/8hhV50SMCgH #RhD #NIPT #Natera #FetalRhD #ACOG2024

Last week, Samantha Leonard and I competed in the 22q Olympics during the International 22q Society biennial scientific conference. We didn’t win any medals but we had the most amazing opportunity to learn from clinicians, researchers, families and advocates committed to raising awareness and moving science forward for 22q. If you want to learn more about 22q and #NIPT, Dr. Leonard is presenting at a webinar this morning hosted by Natera. There is still time to register! https://ow.ly/z88450StWRo

Have you registered for our webinar on July 25th? In this talk, our experts will highlight how early, highly accurate prenatal screening optimizes outcomes for patients with 22q11.2 deletion syndrome and review recently-published data from a large clinical validation study of Fetal RhD NIPT. Register for this event now. #NIPT #RhD #Natera #PrenatalCare

Join our webinar: "The evolution of NIPT: what comes next", featuring Samantha Leonard, MD and vivienne souter, MD, MPH. In this talk, Drs. Leonard and Souter will highlight how early, highly accurate prenatal screening optimizes outcomes for patients with 22q11.2 deletion syndrome, and review data from a large clinical validation study of #Natera's Fetal RhD NIPT. Secure your spot: https://ow.ly/z88450StWRo #NIPT

“We knew each child I was going to have [could] have this same disorder. When we found out about PGT, it was a game changer. PGT gave us the dream of a big family back.” - Vanessa, who received carrier screening while pregnant with her second child. Carrier screening for fragile X can identify the likelihood of having an affected child and provide insight into their own health. Horizon provides an accurate fragile X risk assessment. Learn more: https://ow.ly/w6Pe50SyaxJ #Natera

Have you registered for our webinar on July 25th? In this talk, our experts Samantha Leonard and vivienne souter will highlight how early, highly accurate prenatal screening optimizes outcomes for patients with 22q11.2 deletion syndrome and review data from a large clinical validation study of Fetal RhD NIPT. Register today: https://ow.ly/feiF50SABTW